AFP and Cirrhosis: Recently, Loglio and colleagues investigated the performance of PIVKA-II alone or in combination with AFP in 212 nucleos(t)ide analogues-treated patients with HBV-related cirrhosis (64 HCC and 148 HCC-free controls) for the early detection of HCC during surveillance [32].